Photodynamic therapy for metastatic breast cancer

<p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/k...

Full description

Bibliographic Details
Main Authors: E. V. Horanskaya, M. A. Kaplan, V. N. Kapinous, E. V. Yaroslavtseva, I. S. Spichenkova, A. M. Shubina, O. V. Borgul, Ju. A. Ragulin, M. V. Taibova
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2014-01-01
Series:Biomedical Photonics
Subjects:
Online Access:http://www.pdt-journal.com:80/jour/article/view/33
_version_ 1819072484170792960
author E. V. Horanskaya
M. A. Kaplan
V. N. Kapinous
E. V. Yaroslavtseva
I. S. Spichenkova
A. M. Shubina
O. V. Borgul
Ju. A. Ragulin
M. V. Taibova
author_facet E. V. Horanskaya
M. A. Kaplan
V. N. Kapinous
E. V. Yaroslavtseva
I. S. Spichenkova
A. M. Shubina
O. V. Borgul
Ju. A. Ragulin
M. V. Taibova
author_sort E. V. Horanskaya
collection DOAJ
description <p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/kg body weight 3 h before treatment session (wave length 661±1 nm, плотность мощности 0,11–0,56 J/cm<span><sup>2</sup></span>), мощность на выходе волокна 0,3–2,0 Wt, light dose 50–600 J/cm<span><sup>2</sup></span>. Complete regression of metastasis was obtained in 33.6% of cases, partial – in 39.4%, stabilization – in 22.6%, progression of disease was in 4.3% of cases. The results show the perspectiveness of photodynamic therapy for metastasis as one of the step of treatment.</p><p> </p>
first_indexed 2024-12-21T17:38:27Z
format Article
id doaj.art-7451ba5c02244bb4b2e73034d95b127f
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-12-21T17:38:27Z
publishDate 2014-01-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-7451ba5c02244bb4b2e73034d95b127f2022-12-21T18:55:42ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322014-01-0132151733Photodynamic therapy for metastatic breast cancerE. V. Horanskaya0M. A. Kaplan1V. N. Kapinous2E. V. Yaroslavtseva3I. S. Spichenkova4A. M. Shubina5O. V. Borgul6Ju. A. Ragulin7M. V. Taibova8Национальный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия<p>Results of treatment for cutaneous metastasis of breast cancer with photjdynamic therapy are represented. The study included 46 patients, the total number of treated cutaneous metastases was 535. For photodynamic therapy photosensitizer photolon given intravenously at a dose of 0.9–1.6 mg/kg body weight 3 h before treatment session (wave length 661±1 nm, плотность мощности 0,11–0,56 J/cm<span><sup>2</sup></span>), мощность на выходе волокна 0,3–2,0 Wt, light dose 50–600 J/cm<span><sup>2</sup></span>. Complete regression of metastasis was obtained in 33.6% of cases, partial – in 39.4%, stabilization – in 22.6%, progression of disease was in 4.3% of cases. The results show the perspectiveness of photodynamic therapy for metastasis as one of the step of treatment.</p><p> </p>http://www.pdt-journal.com:80/jour/article/view/33рак молочной железыфотолонфотодинамическая терапиявнутрикожные метастазы
spellingShingle E. V. Horanskaya
M. A. Kaplan
V. N. Kapinous
E. V. Yaroslavtseva
I. S. Spichenkova
A. M. Shubina
O. V. Borgul
Ju. A. Ragulin
M. V. Taibova
Photodynamic therapy for metastatic breast cancer
Biomedical Photonics
рак молочной железы
фотолон
фотодинамическая терапия
внутрикожные метастазы
title Photodynamic therapy for metastatic breast cancer
title_full Photodynamic therapy for metastatic breast cancer
title_fullStr Photodynamic therapy for metastatic breast cancer
title_full_unstemmed Photodynamic therapy for metastatic breast cancer
title_short Photodynamic therapy for metastatic breast cancer
title_sort photodynamic therapy for metastatic breast cancer
topic рак молочной железы
фотолон
фотодинамическая терапия
внутрикожные метастазы
url http://www.pdt-journal.com:80/jour/article/view/33
work_keys_str_mv AT evhoranskaya photodynamictherapyformetastaticbreastcancer
AT makaplan photodynamictherapyformetastaticbreastcancer
AT vnkapinous photodynamictherapyformetastaticbreastcancer
AT evyaroslavtseva photodynamictherapyformetastaticbreastcancer
AT isspichenkova photodynamictherapyformetastaticbreastcancer
AT amshubina photodynamictherapyformetastaticbreastcancer
AT ovborgul photodynamictherapyformetastaticbreastcancer
AT juaragulin photodynamictherapyformetastaticbreastcancer
AT mvtaibova photodynamictherapyformetastaticbreastcancer